LJAC
VRTX icon

L.J. Altfest & Co’s Vertex Pharmaceuticals VRTX Stock Holding History

L.J. Altfest & Co’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
2,030
+1,530
+306% +$678K 0.1% 132
2026
Q1 		$223K Sell
500
-1,324
-73% -$617K 0.02% 305
2025
Q4 		$827K Buy
1,824
+67
+4% +$28.9K 0.09% 156
2025
Q3 		$688K Sell
1,757
-9
-0.5% -$3.76K 0.08% 182
2025
Q2 		$786K Buy
1,766
+120
+7% +$55.3K 0.09% 151
2025
Q1 		$798K Buy
1,646
+975
+145% +$454K 0.1% 144
2024
Q4 		$270K Sell
671
-972
-59% -$451K 0.03% 281
2024
Q3 		$764K Buy
1,643
+171
+12% +$82.1K 0.1% 155
2024
Q2 		$690K Buy
1,472
+35
+2% +$15.2K 0.09% 150
2024
Q1 		$601K Buy
1,437
+5
+0.3% +$2.11K 0.09% 170
2023
Q4 		$583K Sell
1,432
-18
-1% -$6.65K 0.08% 166
2023
Q3 		$504K Sell
1,450
-82
-5% -$28.7K 0.08% 177
2023
Q2 		$539K Buy
1,532
+76
+5% +$25.6K 0.08% 173
2023
Q1 		$459K Buy
1,456
+176
+14% +$52.8K 0.07% 179
2022
Q4 		$370K Sell
1,280
-1,175
-48% -$358K 0.06% 188
2022
Q3 		$711K Sell
2,455
-3
-0.1% -$863 0.13% 109
2022
Q2 		$693K Sell
2,458
-569
-19% -$152K 0.12% 116
2022
Q1 		$790K Buy
3,027
+81
+3% +$19.2K 0.14% 114
2021
Q4 		$647K Sell
2,946
-15
-0.5% -$2.92K 0.12% 124
2021
Q3 		$537K Buy
2,961
+1,170
+65% +$228K 0.11% 131
2021
Q2 		$361K Buy
1,791
+216
+14% +$45.2K 0.08% 186
2021
Q1 		$338K Buy
1,575
+22
+1% +$4.83K 0.08% 194
2020
Q4 		$367K Buy
+1,553
New +$356K 0.09% 167

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

L.J. Altfest & Co's VRTX Position: Q2 2026 in Review

L.J. Altfest & Co increased its Vertex Pharmaceuticals (VRTX) stake by 306% in Q2 2026, buying an estimated $678K and bringing the position to 2,030 shares worth $1.01M. The position accounts for 0.1% of the portfolio, ranked #132.

L.J. Altfest & Co first reported a position in VRTX in Q4 2020 and has held it in 23 quarters since. 1,759 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • L.J. Altfest & Co held 2,030 shares of Vertex Pharmaceuticals worth $1.01M as of Q2 2026.
  • L.J. Altfest & Co bought 1,530 Vertex Pharmaceuticals shares in Q2 2026, an estimated $678K.
  • Vertex Pharmaceuticals made up 0.1% of L.J. Altfest & Co's portfolio in Q2 2026, its #132 holding.
  • L.J. Altfest & Co first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • 1,759 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on L.J. Altfest & Co's 13F filing for Q2 2026, filed 30 Jul 2026.